Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandow

Showing results (121-130 of 580) with videos related to

Pageof 58
Sort By:
American Journal of Clinical Oncology|January 1, 1988
Pharmacological studies on androgen suppression in therapy of prostate carcinomaJ Sandow, W von Rechenberg, K Engelbart
Endocrinology|May 1, 1972
Stimulation of growth hormone release by anterior pituitary perfusion in the ratJ Sandow, A Arimura, A V Schally
The American Journal of Physiology|April 1, 1970
Zinc 65 distribution and movement in frog skeletal muscle and tendonA Isaacson, C P Bianchi, A Sandow
Journal of Shoulder and Elbow Surgery|September 22, 2024
Access to shoulder arthroplasty in Australia: A balance of regulation, surveillance, and monitored efficacy to maximize patient outcome and optimum careMichael J Sandow, David R J Gill
Progress in Clinical and Biological Research|January 1, 1986
Pharmacology and experimental basis of therapy with LHRH agonists in womenJ Sandow, H M Fraser, F Geisthövel
Leukemia Research Reports|January 26, 2024
Avapritinib treatment of aggressive systemic mastocytosis with a novel KIT exon 17 mutationLyndsey Sandow, Ajia Town, Michael C Heinrich
European Endocrinology|April 11, 2018
Equivalent Recombinant Human Insulin Preparations and their Place in TherapyJuergen Sandow, Wolfgang Landgraf, Reinhard Becker, et al.
Acta Virologica|May 1, 1988
Calculation of the frequency of congenital rubella syndrome in PolandD Imbs, D Sandow, N Denkmann, et al.
Journal of Environmental Management|May 15, 2007
Hydrochemical evaluation of the Voltaian system--the Afram Plains area, GhanaSandow Mark Yidana, Duke Ophori, Bruce Banoeng-Yakubo
European Urology|April 22, 2006
Duration of testosterone suppression after a 9.45 mg implant of the GnRH-analogue buserelin in patients with localised carcinoma of the prostate a 12-month follow-up studyBill Pettersson, Eberhard Varenhorst, Anssi Petas, et al.
Pageof 58

Showing results (121-130 of 580) with videos related to

Sort By:
Pageof 58
American Journal of Clinical Oncology|January 1, 1988
Pharmacological studies on androgen suppression in therapy of prostate carcinomaJ Sandow, W von Rechenberg, K Engelbart
Endocrinology|May 1, 1972
Stimulation of growth hormone release by anterior pituitary perfusion in the ratJ Sandow, A Arimura, A V Schally
The American Journal of Physiology|April 1, 1970
Zinc 65 distribution and movement in frog skeletal muscle and tendonA Isaacson, C P Bianchi, A Sandow
Journal of Shoulder and Elbow Surgery|September 22, 2024
Access to shoulder arthroplasty in Australia: A balance of regulation, surveillance, and monitored efficacy to maximize patient outcome and optimum careMichael J Sandow, David R J Gill
Progress in Clinical and Biological Research|January 1, 1986
Pharmacology and experimental basis of therapy with LHRH agonists in womenJ Sandow, H M Fraser, F Geisthövel
Leukemia Research Reports|January 26, 2024
Avapritinib treatment of aggressive systemic mastocytosis with a novel KIT exon 17 mutationLyndsey Sandow, Ajia Town, Michael C Heinrich
European Endocrinology|April 11, 2018
Equivalent Recombinant Human Insulin Preparations and their Place in TherapyJuergen Sandow, Wolfgang Landgraf, Reinhard Becker, et al.
Acta Virologica|May 1, 1988
Calculation of the frequency of congenital rubella syndrome in PolandD Imbs, D Sandow, N Denkmann, et al.
Journal of Environmental Management|May 15, 2007
Hydrochemical evaluation of the Voltaian system--the Afram Plains area, GhanaSandow Mark Yidana, Duke Ophori, Bruce Banoeng-Yakubo
European Urology|April 22, 2006
Duration of testosterone suppression after a 9.45 mg implant of the GnRH-analogue buserelin in patients with localised carcinoma of the prostate a 12-month follow-up studyBill Pettersson, Eberhard Varenhorst, Anssi Petas, et al.
Pageof 58